Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

All living organisms deploy cell-autonomous defenses to combat infection. In plants and animals, large supramolecular complexes often activate immune proteins for protection. In this work, we resolved the native structure of a massive host-defense complex that polymerizes 30,000 guanylate-binding proteins (GBPs) over the surface of gram-negative bacteria inside human cells. Construction of this giant nanomachine took several minutes and remained stable for hours, required guanosine triphosphate hydrolysis, and recruited four GBPs plus caspase-4 and Gasdermin D as a cytokine and cell death immune signaling platform. Cryo-electron tomography suggests that GBP1 can adopt an extended conformation for bacterial membrane insertion to establish this platform, triggering lipopolysaccharide release that activated coassembled caspase-4. Our "open conformer" model provides a dynamic view into how the human GBP1 defense complex mobilizes innate immunity to infection.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12091997PMC
http://dx.doi.org/10.1126/science.abm9903DOI Listing

Publication Analysis

Top Keywords

human gbp1
8
gbp1 defense
8
defense complex
8
immunity infection
8
native architecture
4
architecture human
4
complex cell-autonomous
4
cell-autonomous immunity
4
infection living
4
living organisms
4

Similar Publications

The interferon (IFN)-inducible GTPases play a crucial role in cell autonomous immunity against intracellular pathogens. Particularly, these GTPases directly recognize the host membrane-derived vacuole containing pathogens and subsequently destroy it. Although it has been revealed that these GTPases target the membrane of ()-containing vacuole (LCV), molecular mechanism has been totally uncleared.

View Article and Find Full Text PDF

Guanylate-binding proteins (GBPs) are interferon-inducible proteins that demonstrate a wide spectrum of antimicrobial activity. The capacity of GBPs to undergo nucleotide-dependent oligomerization and to exhibit GTPase activity, together with their membrane-anchoring properties, constitutes a compelling research domain within mechanistic biology. However, the current knowledge regarding GBPs is fragmentary, warranting a comprehensive review to elucidate their significance and to delineate their multifaceted roles in human health and disease.

View Article and Find Full Text PDF

Bat-specific adaptations in interferon signaling and GBP1 contribute to enhanced antiviral capacity.

Nat Commun

July 2025

Laboratory of Zoonotic Viruses and Comparative Immunology, Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, SK, Canada.

Bats are reservoirs of emerging zoonotic viruses that may cause severe disease in humans and agricultural animals. However, it is poorly understood how bats can tolerate diverse viral infections. Here, we characterized type I interferon response pathways in kidney cell lines derived from two divergent bat species, Pteropus alecto and Eptesicus fuscus, identifying distinct mechanisms underlying their enhanced control of viral infection.

View Article and Find Full Text PDF

Multifaceted Roles of Guanylate-Binding Proteins in Cancer.

Int J Mol Sci

June 2025

Brain Tumor Research Centre of Excellence, Peninsula Medical School, University of Plymouth, Plymouth PL6 8BU, UK.

Guanylate-binding proteins (GBPs), encompassing GBP1 through GBP7 in humans, are interferon-inducible large GTPases of the dynamin superfamily, renowned for their pivotal roles in cell-autonomous immunity against intracellular pathogens such as viruses, bacteria, and protozoa. By recognizing pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs), GBPs orchestrate lysosomal targeting, regulate inflammatory cascades, and modulate apoptosis to protect host tissues from immune-mediated damage. Beyond their foundational roles in immunity, GBPs exhibit context-dependent effects in human cancer, promoting malignancy in some tumors through enhanced immune signaling, inhibition of apoptosis, and resistance to therapies, or suppressing tumor growth through immune activation and cell cycle regulation.

View Article and Find Full Text PDF

Triple-negative breast cancer (TNBC) remains one of the most aggressive Triple-negative breast cancer (TNBC) remains one of the most aggressive and therapeutically challenging breast cancer subtypes, largely due to its lack of targetable receptors and its intrinsic chemoresistance. In this study, we applied an integrative multi-omics approach - combining single-cell RNA sequencing (scRNA-seq) with bulk transcriptomic, epigenomic, and mutational analyses, to investigate the cellular heterogeneity and underlying mechanisms of drug resistance in TNBC. Analysis of the scRNA-seq dataset (GSE176078) revealed a complex tumor microenvironment with a highly plastic cancer epithelial subpopulation (Cluster C4) exhibiting elevated multipotency and distinct intercellular communication patterns.

View Article and Find Full Text PDF